The Business of Pride Business of Pride Annual Celebration and Awards Ceremony! Another big biotech pledges billions for U.S. manufacturing Another big biotech pledges billions for U.S ...

Performance data quoted represents past performance, which does not guarantee future results. Current performance may be lower or higher than the figures shown. Principal value and investment ...

Conduct your own due diligence and consult a financial adviser before making any investment decisions. While biotechnology (BioTech) is a very large field, its largest impact is in medicine. For a ...

The biotech sector had suffered a steep decline by the end of 2021. While it is far from recovered, this generalized “Biotech Rout’ have also put the stock of individual attractive company under their ...

This cutting-edge field represents the convergence of artificial intelligence, sensor technology, and biotechnology. For investors looking beyond the quarterly hype cycle, this emerging sector ...

The offers received by Acelyrin include Concentra Biosciences’ attempt to buy the biotech for $3 a share. Acelyrin rejected that takeover bid in March. Tang Capital Partners, an investment firm ...

Shenzhen Genocury Biotech Co., Ltd. is a clinical-stage biotechnology pioneer redefining in vivo cell engineering through its proprietary Vivoexpress™ platform. This modular delivery system ...

Oversupply and demand dampened by a pullback in venture capital have plagued biotech landlords for more than a year, causing steep increases in vacancy in even the top life sciences markets.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach ...